Charité – Universitätsmedizin Berlin and Siemens Healthineers are expanding their long-standing partnership to focus on preventive medicine. Through a new cooperation agreement, the two institutions aim to develop innovative strategies to prevent diseases and promote health by combining their respective strengths in research, clinical practice, and medical technology. The collaboration […]
admin
Meet L•AI•C: Life Time’s AI Revolution in Health and Fitness
Not sure how to structure today’s upper body session or wondering which supplements align with your goals? Life Time’s AI-powered companion for a healthy lifestyle, L•AI•C (pronounced “lay-see”), is now accessible to all users through the free Life Time app. Designed to deliver instant, science-based advice across fitness, nutrition, recovery, […]
Cardinal Health RBC 2025: Honoring the Voice of Independent Pharmacy
More than 4,000 independent pharmacists came together at Cardinal Health’s 2025 Retail Business Conference (RBC) in Denver to network, receive ideas, and develop fresh approaches to enhancing patient care and business operations. Despite continued reimbursement challenges and evolving industry dynamics, independent pharmacies are successfully adapting by expanding revenue opportunities and […]
From Lab to Clinic: Kinvard Bio Accelerates Antibiotic Pipeline with CARB-X Support
Kinvard Bio Inc., a biotechnology firm at the forefront of developing a new generation of broad-spectrum antibiotics, has announced the receipt of US $2.7 million in follow-on non-dilutive funding from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator). This global non-profit initiative supports the acceleration of antibacterial innovation with the goal of […]
Roche Unveils Advancements in Alzheimer’s Pipeline at Toronto Conference
Roche will present new data from its Alzheimer’s development portfolio at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada, from July 27 to 30. These results demonstrate Roche’s all-encompassing approach to treating Alzheimer’s disease at every stage of the patient journey. Key presentations highlight results from the Phase Ib/IIa […]
Akeso’s Ivonescimab Moves Closer to Approval with Third sNDA Acceptance in China
Akeso, Inc. has officially announced that the National Medical Products Administration (NMPA) in China has accepted its supplementary New Drug Application (sNDA) for ivonescimab, a PD-1/VEGF bispecific antibody. The application seeks approval for ivonescimab in combination with chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC). […]
Merck to Showcase Latest HIV Prevention and Treatment Research at IAS 2025
Merck also known as MSD outside the U.S. and Canada, announced that it will present new research data on HIV prevention and treatment at the 13th International AIDS Society Conference on HIV Science (IAS 2025), scheduled for July 13-17, 2025, in Kigali, Rwanda. The business will showcase scientific advancements from […]
CD40/CD40L Inhibitors: Unlocking the Future of Autoimmune and Transplant Therapies
DelveInsight’s comprehensive analysis of the CD40/CD40L inhibitors market delivers a detailed understanding of current treatment trends, the scope of the target population, and an evaluation of the competitive landscape with a forecast extending to 2034. The report places emphasis on indications where CD40/CD40L inhibitors hold potential, including systemic lupus erythematosus […]
Matrix Deepens Commitment to In-Home Care with New Diagnostic Partner
Matrix Medical Network, a recognized leader in delivering high-quality, home-based healthcare services, has announced a strategic partnership with Molecular Testing Labs (MTL), a CLIA- and New York State-certified, CAP-accredited laboratory known for its innovation and excellence in molecular diagnostics. This collaboration marks a significant step forward in Matrix’s ongoing commitment […]
BioLab Investigates Real-World Impact of Amnion Grafts in Chronic Wounds
BioLab Holdings, Inc., a medical manufacturer headquartered in Phoenix and specializing in regenerative medicine and wound healing solutions, has launched a new multicenter hybrid platform trial to assess the clinical effectiveness of its amnion-based wound care products. The trial focuses on treating patients with chronic, hard-to-heal diabetic foot ulcers (DFUs) […]
